Novel mutations target distinct subgroups of medulloblastomaGiles Robinson, Richard J. Gilbertson, David Zhao et al.|Nature|2012Cited by 853
Integrated Molecular Genetic Profiling of Pediatric High-Grade Gliomas Reveals Key Differences With the Adult DiseaseBarbara S. Paugh, Suzanne J. Baker, Chunxu Qu et al.|Journal of Clinical Oncology|2010Cited by 657
Risk stratification of childhood medulloblastoma in the molecular era: the current consensusVijay Ramaswamy, Scott L. Pomeroy, Marc Remke et al.|Acta Neuropathologica|2016Cited by 650
Entrectinib in children and young adults with solid or primary CNS tumors harboring <i>NTRK</i>, <i>ROS1</i>, or <i>ALK</i> aberrations (STARTRK-NG)Ami V. Desai, Elizabeth Fox, Giles Robinson et al.|Neuro-Oncology|2022Cited by 136
Benefit from prolonged dose-intensive chemotherapy for infants with malignant brain tumors is restricted to patients with ependymoma: a report of the Pediatric Oncology Group randomized controlled trial 9233/34Douglas Strother, Amar Gajjar, Lucie Lafay‐Cousin et al.|Neuro-Oncology|2013Cited by 81